{"category": "spam", "to_address": "cruiseca@flax9.uwaterloo.ca", "from_address": "\"Stents Health Alert Newsletter\" <return@bandanestring.com>", "subject": "Drug Coated Stents - Health Alert Newsletter", "body": "Drug Coated Stents \n- Health Alert Newsletter - May 7th, 2007 \nThe U.S. Food and Drug Administration, or FDA, have cited studies \n showing\n  showing drug-coated stent recipients face an increased risk of blood-clots.\nDrug-coated stents, which are sold in the U.S. by Boston Scientific and \nJohnson & Johnson, are designed to prevent scar tissue from forming in \narteries after angioplasty. However, recent studies have suggested \nthe devices might increase the risk of blood clots compared with bare-metal stents.\n  \nDrug-coated stents have been placed in about 6 million \n  people worldwide. \nIf \n  you or someone you know has had a drug-coated stent implanted they may be at \n  risk.\n If so, you or that someone may be entitled to monetary \n  damages.\n\u00a0\n\n\n---------------------------------------------------\nTo \n  stop receiving announcements about Drug Coated Stents:\n\n  UHaveALawyer\n  3 Bethesda Metro Center, Suite 110\n  Bethesda, MD.  20814\nUHaveALawyer is not associated with Johnson & Johnson or Boston Scientific.\n\n  This email is Attorney Advertising\n\n\n______________________________________________________\n\n\n\n"}